Primary ectopic breast carcinoma is a rare disease and, at present, no specific guidelines on its diagnosis and treatment are available. The purpose of this article is to review the world literature in English on primary ectopic breast carcinoma located in the armpit and to offer guidelines for diagnosis and treatment.Data for this review were identified by searches of MEDLINE, PubMed, The Cochrane Library, ACNP (Italian catalogue of journals) and references from relevant articles using relevant search terms and data published in the previous reviews.Primary ectopic breast carcinoma of the axilla mostly affects women of over 40 (range 28-90 yrs) years of age. The most frequent histological diagnosis is invasive ductal carcinoma not otherwis...
Axillary surgery is an established part of the management of primary breast cancer. It provides stag...
This thesis aimed to provide insights into different aspects of the axillary management of breast ca...
Introduction: Various options for axillary staging after neoadjuvant systemic therapy (NST) are avai...
Primary ectopic breast carcinoma is a rare disease and, at present, no specific guidelines on its di...
Primary ectopic breast carcinoma is a rare disease and, at present, no specific guidelines on its di...
Aims: Primary ectopic breast cancer (PEBC) is a rare and often misdiagnosed condition. Through the d...
Data about the occurrence of primary carcinoma in ectopic breast tissue are rare and limited to smal...
Abstract Introduction Ectopic breast tissue is present in 2–6% of women. Ectopic breast cancer repre...
The cutaneous apocrine carcinomas are malignant tumors rare adnexal, slowly and preferably located i...
Ectopic breast tissue (EBT) is found in no more than 6% of the population. The axilla is the most co...
Ductal carcinoma in situ (DCIS) represents a challenge for the breast unit team, beginning from its ...
Background: Squamous cells are normally not found inside the breast, so a primary squamous cell carc...
The aims of this Oncoplastic Breast Consortium and European Breast Cancer Research Association of Su...
Herein, we describe our clinical experience on the management of patients with ectopic breast tissue...
Primary breast cancer in aberrant axillary breast tissue is rare. Breast cancer in the axilla is mos...
Axillary surgery is an established part of the management of primary breast cancer. It provides stag...
This thesis aimed to provide insights into different aspects of the axillary management of breast ca...
Introduction: Various options for axillary staging after neoadjuvant systemic therapy (NST) are avai...
Primary ectopic breast carcinoma is a rare disease and, at present, no specific guidelines on its di...
Primary ectopic breast carcinoma is a rare disease and, at present, no specific guidelines on its di...
Aims: Primary ectopic breast cancer (PEBC) is a rare and often misdiagnosed condition. Through the d...
Data about the occurrence of primary carcinoma in ectopic breast tissue are rare and limited to smal...
Abstract Introduction Ectopic breast tissue is present in 2–6% of women. Ectopic breast cancer repre...
The cutaneous apocrine carcinomas are malignant tumors rare adnexal, slowly and preferably located i...
Ectopic breast tissue (EBT) is found in no more than 6% of the population. The axilla is the most co...
Ductal carcinoma in situ (DCIS) represents a challenge for the breast unit team, beginning from its ...
Background: Squamous cells are normally not found inside the breast, so a primary squamous cell carc...
The aims of this Oncoplastic Breast Consortium and European Breast Cancer Research Association of Su...
Herein, we describe our clinical experience on the management of patients with ectopic breast tissue...
Primary breast cancer in aberrant axillary breast tissue is rare. Breast cancer in the axilla is mos...
Axillary surgery is an established part of the management of primary breast cancer. It provides stag...
This thesis aimed to provide insights into different aspects of the axillary management of breast ca...
Introduction: Various options for axillary staging after neoadjuvant systemic therapy (NST) are avai...